immunologic response
Showing 1 - 25 of >10,000
Glioblastoma, Gliosarcoma, Malignant Glioma Trial run by the NCI (TMZ, ipilimumab 3mg/kg, Nivolumab)
Recruiting
- Glioblastoma
- +2 more
- TMZ
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 31, 2023
Tests in the Diagnosis of COVID-19 in Pediatrics
Recruiting
- COVID-19
-
Trieste, ItalyIRCCS Burlo Garofolo
Mar 31, 2023
Asplenia Trial in Sacramento (Pneumovax-23)
Recruiting
- Asplenia
- Pneumovax-23
-
Sacramento, CaliforniaUniversity of California, Davis Medical Center
Jan 26, 2022
Melanoma Stage III, Melanoma Stage IV Trial in Louisville (Beta-Glucan)
Recruiting
- Melanoma Stage III
- Melanoma Stage IV
- Beta-Glucan
-
Louisville, KentuckyUniversity of Louisville
Jan 7, 2022
HIV, Human Immunodeficiency Virus Trial in Salt Lake City (Euphorbia kansui extract powder prepared as tea)
Suspended
- HIV
- Human Immunodeficiency Virus
- Euphorbia kansui extract powder prepared as tea
-
Salt Lake City, UtahUniversity of Utah
Mar 22, 2022
NSCLC Stage I Trial in Baltimore (Post-SABR Biopsy)
Recruiting
- Non-small Cell Lung Cancer Stage I
- Post-SABR Biopsy
-
Baltimore, MarylandBayview Medical Center
Nov 23, 2021
(VIII): The Eight Study and Immunologic Response Sub-study
Recruiting
- Vaccine Reaction
-
Chicago, Illinois
- +1 more
Feb 2, 2022
Influenza, Human, Immune Response Trial in Pittsburgh (FluMist live attenuated influenza vaccine, Flucelvax inactivated
Completed
- Influenza, Human
- Immune Response
- FluMist live attenuated influenza vaccine
- Flucelvax inactivated influenza vaccine
-
Pittsburgh, Pennsylvania
- +1 more
Sep 17, 2021
Cryoablation Versus Radiofrequency Ablation in Treatment of
Terminated
- Immune Response to 3 Approaches
- (no location specified)
Apr 15, 2021
Bronchiectasis, Cystic Fibrosis, Primary Ciliary Dyskinesia Trial in Haifa (spirometry, Salbutamol, )
Recruiting
- Bronchiectasis
- +4 more
- spirometry
- +2 more
-
Haifa, IsraelRambam Health Campus
Jun 30, 2023
Individuals With and Without Immune Deficiencies and
Recruiting
- Immunodeficiencies
- Immune Dysregulations
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 6, 2023
Advanced Solid Tumor Trial in Portland (HS-110 (viagenpumatucel-L), HS-130)
Active, not recruiting
- Advanced Solid Tumor
- HS-110 (viagenpumatucel-L)
- HS-130
-
Portland, OregonProvidence Portland Medical Center
Feb 2, 2022
Paravertebral Block, Pectoralis and Serratus Plane Nerve Blocks, Breast Cancer Trial (procedure, device, drug)
Not yet recruiting
- Paravertebral Block
- +4 more
- Paravertebral nerve block (PVB)
- +5 more
- (no location specified)
Apr 3, 2023
COVID19 Vaccination in Immunodeficient Patients
Active, not recruiting
- Multiple Sclerosis
- +2 more
- COVID19 vaccine
-
New Haven, ConnecticutYale University
May 9, 2022
Neuroendocrine Tumors Trial in Napoli (Octreotide Acetate)
Completed
- Neuroendocrine Tumors
- Octreotide Acetate
-
Napoli, ItalyIstitute Nazionale Tumori - Fondazione G. Pascale
Sep 9, 2020
Body Weight, Oxidative Stress, Trimethylamine N-oxide Trial in Poznan (Meatless, restrictive ketogenic diet)
Completed
- Body Weight
- +13 more
- Meatless, restrictive ketogenic diet
-
Poznań, Wielkopolskie, PolandPoznan University of Physical Education
Sep 28, 2022
Following COVID-19 Vaccination in Children, Adolescents, and
Recruiting
- COVID-19 Infection
- +2 more
- Biospecimen Collection
- Survey Administration
-
Birmingham, Alabama
- +54 more
Jan 30, 2023
Breast Cancer, Breast Tumors Trial in Portland (Pembrolizumab, IRX 2)
Recruiting
- Breast Cancer
- Breast Neoplasms
- Pembrolizumab
- IRX 2
-
Portland, OregonProvidence Portland Medical Center
Jan 31, 2022
Psoriasis Trial in San Francisco (Secukinumab)
Completed
- Psoriasis
-
San Francisco, CaliforniaUCSF Psoriasis and Skin Treatment Center
Aug 31, 2020
The Immune System's Response to Young Women's Breast Cancer
Recruiting
- Breast Cancer
- Breast Cancer and Pregnancy
-
Aurora, ColoradoUniversity of Colorado Denver
Nov 3, 2021
Interleukin 4 and Interferon Gamma Predictors of Human
Completed
- Warts Hand
- Wart, Genital
- IL-4 and IFN-γ measurements
-
Zagazig, Sharkia, EgyptZagazig University Faculty of Medicine
Oct 28, 2021
Primary Immune Deficiency Trial run by the NIAID (Pneumovax, Rabavert, Prevnar)
Terminated
- Primary Immune Deficiency
- Pneumovax
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 14, 2021
Tuberculosis, Human Immunodeficiency Virus Trial in Makasar (Active Hexoses Correlated Compound)
Completed
- Tuberculosis
- Human Immunodeficiency Virus
- Active Hexoses Correlated Compound
-
Makasar, South Sulawesi, IndonesiaLabuang Baji General Hospital
Oct 27, 2021
Melanoma Trial in Stockholm (Cyclophosphamide, Fludarabine, T cells)
Recruiting
- Melanoma
- Cyclophosphamide
- +4 more
-
Stockholm, SwedenKarolinska University Hospital
Sep 17, 2020